SEARCH

SEARCH BY CITATION

References

  • 1
    Moss AJ, Parsons VL. Current estimates from the National Health Interview Survey. United States - 1985. In: Hyattsville , Maryland : National Center for Health Statistics. DHHS publication no. (PHS) 68–1588 (Vital and Health Statistics; series 10: no. 160). 1986;667.
  • 2
    Settipane GA, Chaffee FH. Nasal polyps. Am J Rhinol 1987;1:11926.
  • 3
    Gwaltney JM. Microbiology of sinusitis. In: DruceHM. editor. Sinusitis: pathophysiology and treatment, New York : Marcel Dekker. 1994;4156.
  • 4
    Baraniuk JN. Physiology of sinusitis. In: DruceHM. editor. Sinusitis: pathophysioloey and treatment. New York : Marcel Dekker 1994;1939.
  • 5
    Stammberger H. Endoscopic endonasal surgery - concepts in treatment of recurring rhinosinusitis. I. Anatomic and pathophysiological considerations. Otolaryngol Head Neck Surg 1986;94:1437.
  • 6
    Mygind N. Nasal poiyposis. J Allergy Clin Immunol 1990;86(6, pt 1):8279.
  • 7
    Tos M, Sasaki Y, Ohnishi M, Larsen P, Drake LA. Pathogenesis of nasal polyps. Rhinol Suppl 1992;14:1815.
  • 8
    Tokushige E, Itoh K, Ushikai M, Katahira S, Fukuda K. Localization of IL-ip mRNA and cell adhesion molecules in the maxillary sinus mucosa of patients with chronic sinusitis. Laryngoscope 1994;104:124550.
  • 9
    Lund VJ, Henderson B, Song Y. Involvement of cytokines and vascular adhesion molecules in the pathophysiology of fronto-ethmoidal mucoceles. Acta Otolaryngol (Stockh) 1993;113:5406.
  • 10
    Takeuchi K, Yuta A, Sakakura Y. Interleukin-8 expression in chronic sinusitis. Am J Otolaryngol 1995;16:98102.
  • 11
    Suzuki H, Takahashi Y, Wataya H et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 1996;98:65970.
  • 12
    Hamilos DL, Leung DY, Wood R et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukm-3. J Allergy Clin Immunol 1993;92:3948.
  • 13
    Costa JJ, Matossian K, Resnick MB et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993;91:267384.
  • 14
    Ohno I, Lea RG, Flanders KC et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89:16628.
  • 15
    Finotto S, Ohno I, Marshall JS et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:227889.
  • 16
    Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93:8649.
  • 17
    Bachert C, Hauser U, Wagenmann M, Brandt A, Dater I, Prem B. Interleukin-5 protein is detected in nasal polyps [Abstract]. J Allergy Clin Immunol 1995;95:389.
  • 18
    Gwaltney JM, Phillips CD, Riker DK. Computerized tomography study of the common cold. N Engl J Med 1994;330:2530.
  • 19
    Röseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of IL-1β. IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1995;252:S613.
  • 20
    Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:1203.
  • 21
    Bachert C, Wagenmann M, Hauser U. Proinflammatory cytokines: measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Immunol 1995;107:1068.
  • 22
    Winther B, Brofeldt S, Christensen B, Mygind N. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol 1984;97:30918.
  • 23
    Proud B, Gwaltney JM, Hendley JO, Dinarello CA, Gillis S, Schleimer RP. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus cold. J Infect Dis 1994;169:100713.
  • 24
    Noah TL, Henderson FW, Wortman IA et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995;171:58492.
  • 25
    Hussell T, Spender LC, Georgiou A, O'Garra A, Openshaw PJ. TH1 and TH2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 1996;77:244755.
  • 26
    Linden M, Greiff L, Andersson M et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995;25:16672.
  • 27
    De Maeyer E, De Maeyer-Guignard J. Interferons. In: ThomsonAW. editor. The Cytokine handbook. London : Academic Press. 1994;26588.
  • 28
    Mosmann TR. Interleukin-10. In: ThomsonAW. editor. The cytokine handbook. London : Academic Press, 1994;22338.
  • 29
    Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:83947.
  • 30
    Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Marluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990;344:702.
  • 31
    Bachert C, Hauser U, Prem B, Rudack C, Ganzer U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol Suppl 1995;1:S449.
  • 32
    Baroody FM, Lee BJ, Lim MC, Bochner BS. Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol 1995;252:S508.
  • 33
    van Damme J. Interleukin-8 and related molecules. In: ThompsonAW. editor. The cytokine handbook. London : Academic Press. 1991;20114.
  • 34
    Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol 1995;104 Suppl 167:1721.
  • 35
    van Cauwenberge P Ingels K. Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol (Stockh) 1996;116:31621.
  • 36
    Stierna P, Carlsoo B. Histopathological observations in chronic maxillary sinusitis. Acta Otolaryngol (Stockh) 1990;110:4508.
  • 37
    Nishimoto K, Kotaro U Teruhiko H, Shun JC, Sakakura Y. Lymphocyte subsets in maxillary mucosa in chronic inflammation. Acta Otolaryngol (Stockh) 1988;106:2918.
  • 38
    Georgitis JW, Matthews BL, Stone B. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid. Int Arch Allergy Immunol 1995;106:41621.
  • 39
    Harlin SL, Ansel DG, Lane SR et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:86775.
  • 40
    Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amoun'ts of NAP-1/IL-8. J Exp Med 1991;173:7714.
  • 41
    Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor a. Proc Natl Acad Sci U S A 1990;87:675861.
  • 42
    Lindemann A, Riedel D, Oster W, Meuer SC, Blohm D, Mertelsmann RH. Granulocyte/macrophage colonystimulating factor induces interleukin-1 production by human polymorphonuclear neutrophils. J Immunol 1988;140:8379.
  • 43
    Schrader JW. Interleukin-3. In: ThomsonA, editor. The cytokine handbook. London : Academic Press. 1994;8198.
  • 44
    Persson CGA, Erjefalt JS, Andersson M et al. Epithelium, microcirculation and eosinophils - new aspects of the allergic airway in vivo. Allergy 1997;52:24155.
  • 45
    Bachert C. The role of allergy in chronic sinusitis. In: vanCauwenbergeP WangD, IngelsK, BachertC, editors. The nose, Amsterdam : Kugler. 1997 (in press).
  • 46
    Stoop AE. van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993;91:61622.
  • 47
    Jahnsen FL, Halstensen TS, Brandtzaeg P. Erroneous immunohistochemical application of monoclonal antibody EG2 to detect cellular activation. Lancet 1994;344:151415.
  • 48
    Liu CM, Shun CT, Hsu MM. Lymphocyte subsets and antigen-specific igE antibody in nasal polyps. Ann Allergy 1994;72:1924.
  • 49
    Liu Y, Hamaguchi Y, Taya M, Sakakura Y. Ouantification of interlcukin-1 in nasal polyps from patients with chronic sinusitis. Eur Arch Olorhinolaryngol 1993;230:1230.
  • 50
    Hamaguchi Y, Suzumura H, Arima S, Sakakura Y. Ouantitation and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis. Int Arch Allergy Immunol 1994;104:1559.
  • 51
    Ohno I, Lea R, Finotto S et al. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nas;il polyposis. Am J Respir Cell Mol Biol 1991;5:50510.
  • 52
    Vanchieri C, Ohtoshi T, Cox G et al. Neutrophilic differentiation induced by human upper respiratory airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991;4:1117.
  • 53
    Bachert C, Prem B, Däter I. Zytokine in der Polyposisforschung - eine neue Dimension. Allergologie 1994;12:57881.
  • 54
    Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:83742.
  • 55
    Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol 1992;149:40218.
  • 56
    Sehmi R, Cromwell O, Wardlaw J, Moqbel R, Kay B. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from healthy subjects. Clin Exp Allergy 1994;23:102731.
  • 57
    Alam R, Stafford S, Forsythe P Harrison R, Faubion D, Lett Brown MA. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:34428.
  • 58
    Kapp A, Zeck-Kapp G, Czech W, Schopf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 1994;102:90614.
  • 59
    Ebisawa M, Liu MC, Yamada T et al. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophilactive cytokines. J Immunol 1994;152:45906.
  • 60
    Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 1994;153:215360.
  • 61
    Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247 (4941):4569.
  • 62
    Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:108692.
  • 63
    Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1993;179:8817.
  • 64
    Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant. eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment ot eosinophils. J Clin Invest 1996;97:60412.
  • 65
    Marfaing-Koka A, Devergene O, Gorgone G et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995;154:18708.
  • 66
    Beck LA, Schall TJ, Beall LD, Leopold D, Bickel C, Baroody F. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps [Abstract]. J Allergy Clin Immunol 1994;93:234.
  • 67
    Maune S, Meyer JE, Sticherling M, Fotster-Holst P, Schroder JM. Eosinophilen-chemotaktische Aktivitat in der Chemokinfraktion von Nasenpolypen. Allergologie 1996;19:2303.
  • 68
    Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant lor eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:44956.
  • 69
    Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:116974.
  • 70
    Kitaura M, Nakajama T, Imai T et al. Molecular cloning of human eotaxin. an eosinophil-specific CC chemokine, and identification of a specific receptor. CC chemokine receptor 3. J Biol Chem 1996;271:772530.
  • 71
    Eisner J, Hochstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst in human eosinophils. Eur J Immunol 1996;26:191925.
  • 72
    Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:62432.
  • 73
    Nonaka M, Nonaka R, Wooley K et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissue. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 1995;155:323444.
  • 74
    Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;99:39028.
  • 75
    Hamilos DL, Leung DY, Wood R et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996;15:44350.
  • 76
    Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:10914.
  • 77
    Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule-1/very late activation antigen-4 and intercellular adhesion molecule-1/lymphocyte function-associated antigen-1 interactions in antigen-induced eosinophil and 1-cell recruitment into the tissue. J Exp Med 1994;179:114554.
  • 78
    Montefort S, Feather IH, Wilson SJ et al. The expression of leucocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992;7:3938.
  • 79
    Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectindependent. J Exp Med 1994;180:3716.
  • 80
    Hamilos DL, Leung DJ, Wood R et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:53744.
  • 81
    Min YG, Chung JW, Shin JS, Chi JG. Histologic structure of antrochoanal polyps. Acta Otolaryngol (Stockh) 1995;115:5437.
  • 82
    Weiler PF. The immunobiology of eosinophils, N Engl J Med 1991;324:111018.
  • 83
    Her E, Frazer J, Austen KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glueocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991;88:19829.
  • 84
    Simon HU, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia Immunol Today 1995;16:535.
  • 85
    Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988;167:173742.
  • 86
    Broide DH, Paine MM, Firestein G. Eosinophils express IL-5 and GM-CSF mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:141418.
  • 87
    Desreumaux P, Janin A, Dubucquoi S et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1991;82:155360.
  • 88
    Devos R, Guiscz Y, van der Heyden J, Tavernier J. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic disease. J Leukoc Biol 1995;57:81319.
  • 89
    Mauser PJ, Pitman AM, Fernandez X et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:46772.
  • 90
    Okudaira H, Mori A, Kaminuma O, Suko M. IL-5 regulation – a new approach to allergy therapy. Allergy Clin Immunol Int 1995;8:1729.
  • 91
    Devos R, Plaetnick G, van der Heyden J et al. Molecular basis of a high affinity murine interleukin-5 receptor. EMBO J 1991;10:21337.
  • 92
    Tavernier J, Devos R, Tuypens T et al. Human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 1991;66:117584.
  • 93
    Tavernier J, Tuypens T, Plaetnick G, Cornelis S, Verhee A, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin-5 receptor α-subunit, Proc Natl Acad Sci U S A 1992;89:70415.
  • 94
    Venge P. Soluble markers of allergic inflammation. Allergy 1994;49:18.
  • 95
    Bousquet J, Chanez P Lacoste JY et al. Eosinophilic inflammation in asthma, N Engl J Med 1990;323:10339.
  • 96
    Gleich GJ, Abu-Ghazaleh RI, Glitz DG. Eosinophil granule proteins: structure and function. In: GleichGJ, KayAB. editors, Eosinophils in allergy and inflammation. New York : Marcel Dekker. 1994;120.
  • 97
    Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium, Am Rev Respir Dis 1988;138:6858.
  • 98
    Hastie AT Loegering DA, Gleich GJ, Kueppers F. The effect of purified human eosinophil cationic protein on mammalian ciliary activity. Am Rev Respir Dis 1987;135:84855.
  • 99
    Tottrup A, Fredens K, Funch-Jensen P, Aggestrup S, Dahl R. Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role. Dig Dis Sci 1989;34:18949.